CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial
Published Online: 2017-07-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alexandru Eniu•Alexey Manikhas•Andriy Rusyn•Daniil Stroyakovskii•Dmitry Komov•Dmytro Boliukh•Edvard Zhavrid•Francisco J Esteva•Gabriela Morar-Bolba•Giorgi Dzagnidze•Joanna Pikiel•Justin Stebbing•Rubi K Li•Sang Joon Lee•Sung Young Lee•Valeriy Baryash•Vladimir Moiseyenko•Yauheni Baranau
